{
    "id": 3267,
    "fullName": "EGFR H870R",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "EGFR H870R lies within the protein kinase domain of the Egfr protein (UniProt.org). H870R results in constitutive phosphorylation of Egfr, activation of downstream signaling in cell culture (PMID: 19671738), increased cell proliferation and cell viability in culture (PMID: 29533785), and is associated with resistance to Egfr inhibitors (PMID: 19671738).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                },
                {
                    "id": 1878,
                    "pubMedId": 19671738,
                    "title": "Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19671738"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "H870R",
    "createDate": "02/20/2015",
    "updateDate": "11/05/2019",
    "referenceTranscriptCoordinates": {
        "id": 135692,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55191858A>G",
        "cDna": "c.2609A>G",
        "protein": "p.H870R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19064,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, EGFR H870R was insensitive to inhibition of Egfr phosphorylation by Iressa (gefitinib) in non-small cell lung cancer cells in culture (PMID: 19671738).",
            "molecularProfile": {
                "id": 3084,
                "profileName": "EGFR H870R"
            },
            "therapy": {
                "id": 751,
                "therapyName": "Gefitinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 1878,
                    "pubMedId": 19671738,
                    "title": "Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19671738"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19063,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Tarceva (erlotinib) treatment resulted in rapid disease progression within 3 months of treatment in a patient with metastatic lung adenocarcinoma harboring both EGFR L858R and EGFR H870R (PMID: 21841502).",
            "molecularProfile": {
                "id": 33831,
                "profileName": "EGFR L858R EGFR H870R"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 16690,
                    "pubMedId": 21841502,
                    "title": "Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21841502"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3084,
            "profileName": "EGFR H870R",
            "profileTreatmentApproaches": [
                {
                    "id": 17930,
                    "name": "EGFR Inhibitor 3rd gen",
                    "profileName": "EGFR H870R"
                },
                {
                    "id": 17927,
                    "name": "EGFR Inhibitor 1st gen",
                    "profileName": "EGFR H870R"
                },
                {
                    "id": 17929,
                    "name": "EGFR Inhibitor 2nd gen",
                    "profileName": "EGFR H870R"
                },
                {
                    "id": 17931,
                    "name": "HER inhibitor (Pan)",
                    "profileName": "EGFR H870R"
                },
                {
                    "id": 17928,
                    "name": "EGFR Inhibitor (Pan)",
                    "profileName": "EGFR H870R"
                }
            ]
        },
        {
            "id": 33831,
            "profileName": "EGFR L858R EGFR H870R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 135692,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55191858A>G",
            "cDna": "c.2609A>G",
            "protein": "p.H870R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}